A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension | NCT01863953 | Trialant
CompletedInterventionalPhase 2Updated Jan 26, 2015
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
ClinicalTrials.gov ID
NCT01863953
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 2
Enrollment
112Actual
Last Update Posted
Jan 26, 2015Estimated
Start Date
Jun 2013
Primary Completion Date
Dec 2013Actual
Completion Date
Dec 2013Actual
Brief Summary
This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.